Background: Lebanon faces an HIV epidemic concentrated in key populations. The national AIDS programme [NAP] hosted by WHO since 1989 achieved substantial progress towards the 95-95-95 UNAIDS targets. In 2023, we reviewed the programme to guide its planned transition back into the structure of the Ministry of Health [MOH].

Methods: In 2023, we reviewed programme documents, epidemiological information and interviewed relevant stakeholders. We compiled national data along with WHO and UNAIDS estimates to describe the evolution of programme and epidemiological indicators, along with the result chain of input, process, output, outcome and impact.

Results: Domestic funding for the NAP increased from 73% in 2007 to 97% in 2018, before a drop in 2019 because of the financial crisis, when the NAP became dependent on international funding, including the Global Fund (commodities and services) and WHO (human resources). NAP core functions were governance, capacity building, monitoring and evaluation, anti-retro viral treatment [ART] dispensing and follow up for persons living with HIV [PLHIV] with some involvement in procurement, supply chain and laboratory testing. The NAP provided prevention, diagnosis and treatment services through Civil Society Organizations [CSOs]. In 2022, in Lebanon, 86% of PLHIV were diagnosed, among which 93% were on treatment and 95% virally suppressed. In 2022, NAP reported 232 new HIV infections, a 41% increase since 2010 and a 25% decrease in AIDS-related deaths during the same period. The estimated HIV incidence increased 4.4 times among MSM from 2008 to 2019, remained zero among commercial sex workers, and evolved from 0 to 0.11 per 1,000 to 0.9 per 1,000 in 2021 among PWIDs.

Conclusions: Lebanon is on track to achieve the UNAIDS 95-95-95 by 2025 targets. After transition into the MoPH, the NAP will need to [1] identify ways to sustain its sources of domestic funding, [2] build on its collaborations with CSOs to expand prevention activities in key populations, and [3] address the evolving needs of the population, including among transgenders, migrants, displaced people, and refugees, 4) maintain good quality core functions (capacity building, monitoring and evaluation, and medications).

Copyright: © 2025 ElMedrek et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

背景： 黎巴嫩面临集中于关键人群中的艾滋病流行。自1989年以来由世界卫生组织（WHO）主持的国家艾滋病毒计划[NAP]在实现联合国艾滋病规划署（UNAIDS）提出的“95-95-95”目标方面取得了显著进展。2023年，我们审查了该计划以指导其计划回归卫生部[MOH]结构。

方法： 在2023年，我们查阅了项目文件、流行病学信息，并与相关利益攸关方进行了访谈。我们收集了国家数据以及世界卫生组织和联合国艾滋病规划署的估计值，描述了计划和流行病学指标的发展历程，包括投入、过程、产出、结果及影响的结果链。

结果： 国内资金对NAP的支持从2007年的73%增加到2018年的97%，但在2019年因金融危机而下降，在此期间NAP依赖于国际资金，包括全球基金（商品和服务）和世界卫生组织（人力资源）。NAP的核心职能包括治理、能力建设、监测与评估、抗逆转录病毒治疗[ART]分发及对HIV感染者进行跟踪随访。此外，NAP还参与采购、供应链管理和实验室检测等工作。2022年，在黎巴嫩，86%的PLHIV被诊断出来，其中93%的人接受治疗且有95%的人病毒受到抑制。在2022年，NAP报告新增艾滋病病毒感染者232例，自2010年以来增加了41%，同一时期因艾滋病死亡人数减少了25%。从2008年至2019年间，男男性行为者的HIV发病率增加至原来的4.4倍；商业性工作者中的估计HIV感染率一直为零，在注射吸毒者中，HIV的估计发病率从2021年的每千人中有0.11例上升到0.9例。

结论： 黎巴嫩正朝着在2025年实现联合国艾滋病规划署“95-95-95”目标的方向前进。过渡到卫生部之后，NAP需要[1]找到保持国内资金来源的方法；[2]利用与民间社会组织的合作，扩大对关键人群的预防活动范围；以及[3]应对人口不断变化的需求，包括跨性别者、移民、流离失所的人和难民的需求，并且[4]维持高质量的核心功能（能力建设、监测与评估以及药物管理）。

版权：© 2025 ElMedrek等人。本作品为开放获取文章，根据创用CC 姓名标示许可协议分发，该许可允许在任何媒介上无限制使用、分发和复制原始作者及来源得到适当标注的情况下。